FOXM1 and neoplasm: Although parental tumor was highly sensitive to TKI treatments, the FOXM1 + sgFOXA1 tumor exhibited strong TKI resistance, with 80% (4/5) tumors showing 60%–90% volume increase upon drug treatments (Fig. 6E–H).